Deftfaker
Lv11
80 积分
2024-01-19 加入
-
Cost-Effectiveness of First-Line Versus Second-Line Use of Daratumumab in Older, Transplant-Ineligible Patients With Multiple Myeloma
3小时前
待确认
-
Early versus delayed stenting for intracranial atherosclerotic artery stenosis with ischemic stroke
2个月前
已完结
-
DNA damage induces p53-independent apoptosis through ribosome stalling
3个月前
已完结
-
First-principles calculations of the structural, electronic, optical and elastic properties of the CuYS2 semiconductor
3个月前
已完结
-
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
6个月前
已完结
-
Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapy in Multiple Myeloma: Moving Into the Future
6个月前
已完结
-
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study
6个月前
已完结
-
Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): updated outcomes from a randomised, multicentre, open-label, phase 3 study
6个月前
已完结
-
Effects of multiple exposures to general anesthesia on the sleep quality of children after plastic surgery in Beijing, China: a cohort study
6个月前
已完结
-
The results of a pharmacoeconomic study: incremental cost-effectiveness ratio versus net monetary benefit
7个月前
已完结